Loading...
A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer
BACKGROUND: This study was designed to determine the efficacy and tolerability of a novel two-week regimen of capecitabine, oxaliplatin and bevacizumab in patients with chemo-naive advanced colorectal cancer. PATIENTS AND METHODS: Nineteen patients with previously untreated advanced colorectal cance...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4120818/ https://ncbi.nlm.nih.gov/pubmed/21855046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2011.03.018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|